Browse > Article

Purification and Characterization of Trypsin Inhibitor from Alismatis Rhizoma and its Binding Protein, 10-Formyltetrahydrofolate Dehydrogenase  

Kim, Ji-Man (College of Pharmacy, Kyungsung University)
Park, Jong-Ok (Department of Chemistry, College of Science, Kyungsung University)
Shin, Young-Hee (College of Pharmacy, Kyungsung University)
Publication Information
YAKHAK HOEJI / v.52, no.1, 2008 , pp. 79-84 More about this Journal
Abstract
Alismatis Rhizoma has been used as diuretics and antiphlogistics in the Chinese oriental medicine. A trypsin inhibitor was isolated from Alismatis Rhizoma using DEAE ion exchange column, trypsin affinity column, and FPLC chromatography, and its activity and characteristics were studied. The purifed Alismatis Rhizoma trypsin inhibitor (ARTI) was estimated to be about 22 kDa. The sequence determination on N-terminal amino acid residues and 84 amino acid residues has been completed, yet no homology has been found with trypsin inhibitors reported at NCBI. ARTI did not show inhibitory activities on chymotrypsin and elastase, however it exhibited a significant inhibitory activity on bovine trypsin, and formed a complex with rat liver 10-formyltetrahydrofolate dehydrogenase.
Keywords
Alsmatis Rhizoma trypsin inhibitor (ARTI); partial amino acid sequence; ARTI-affinity column; 10-formyltetrahydrofolate dehydrogenase (FDH);
Citations & Related Records
연도 인용수 순위
  • Reference
1 Iwama, H., Nakane, M., Ohmori, S., Kaneko, T., Kato, M., Watanabe, K. and Okuaki, A. : Nafamostat mesilate, a kalliklein inhibitor, prevents pain on injection with propofol. Br. J. Anaesth. 81, 963 (1998)
2 Matsumoto, K., Yamamoto, T., Kamata, R. and Maeda, H. : Enhancement of vascular permeability upon serratial infection: activation of Hageman factor-kallikrein-kinin cascade. Adv. Exp. Med. Biol. 198, 71 (1987)
3 Shin, Y. H., Kojima, Y., Otagiri, M. and Maeda, H. : Conjugation of succinylated gelatin to soybean trypsin inhibitor. Bioactive Compatible Polymers 11, 3 (1996)
4 Shin, Y. H., Akaike, T., Khan, M. H., Sakada, Y. and Maeda, H. : Futher evidence of bradykinin involvement in septic shock: reduction of kinin production in vivo and improved survival in rats by use of polymer tailored SBTI with longer $t_{1/2}$. Immunopharmacology 33, 369 (1996)
5 Krupenko, S. A., Wagner, C. and Cook, R. J. : Domain structure of rat 10-formyltetrahydrofolate dehydrogenase. resolution of the amino-terminal domain as 10-Formyltetrahydrofolate hydrolase. J. Biol. Chem. 272, 10273 (1997)
6 Colasanti, M., Persichini, T., Venturini, G., Menegati, E., Lauro, G. M. and Ascenzi, P. : Effect of gabexate mesylate, a drug for serine protease mediated diseases, on the nitric oxide pathway. Biochem. Biophys. Res. Commun. 246, 456 (1998)
7 Park, J. O. and Lee, I. S. : Purification and characterization of trypsin inhibitor from Alismatis Rhizoma. Kor. J. Life Sci. 12, 151 (2002)
8 Fullmer, C. S. : Identification of cysteine-containing peptides in protein digests by high-performance liquid chromatography. Anal. Biochem. 142, 336 (1985)
9 Krupenko, S. A. and Wagner, C. : Aspartate 142 involved in both hydrolase and dehydrogenase catalytic centers of 10-formyltetrahydrofolate dehydrogenase. J. Biol. Chem. 274, 35777 (1999)
10 Krupenko, S. A., Wagner, C. and Cook, R. J. : Domain structure of Rat 10-formyltetrahydrofolate dehydrogenase. J. Biol. Chem. 272, 10273 (1997)
11 Koo, S. H., Choi, Y. L., Choi, S. K., Shin, Y. H., Kim, B. G. and Lee, B. L. : Purification and characterization of serine protease inhibitors from Dolichos lablab seeds; Prevention effects on pseudomonal elastase-induced septic hypotension. J. Biochem. 33, 112 (2000)
12 Hayashi, O. : Protease and protease inhibitor, Medical view, Tokyo, Japan (1993)
13 Matsuda, H., Tomohiro, N., Yoshikawa, M. and Kubo, M. : Anticomplementary activities of methanol extract and terpene components from Alismatis Rhizoma. Biol. Pharm. Bull. 21, 1317 (1998)
14 Schirch, D., Villa, E., Maras, B., Barras, D. and Schirch, V. : Domain structure and function of 10-formyltetrahydrofolate dehydrogenase. J. Biol. Chem. 269, 24728 (1994)
15 Krupenko, S. A., Vlasov, A. P. and Wagner, C. : On the role of conserved histidine 106 in 10-formyltetrahydrofolate dehydrogenase catalysis. J. Biol. Chem. 276, 24030 (2001)
16 Barrett, A. J., Rawlings, N. D. and Woessner, J. F. : Hand book of proteolytic enzymes. Academic press, Inc., London (1998)
17 Ooka, T., Hatano, Y., Yamamoto, M., Ogawa, K. and Saika, S. : Protective effects of human urinary trypsin inhibitor against trypsin-induced relaxation in rat aorta. Crit. Care. Med. 24, 1903 (1996)
18 Laemmli, U. K. : Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680 (1970)
19 Lee, S. M., Kho, Y. H., Min, B. S., Kim, J. H., Na, M. K., Kang, S. J., Maeng, H. Y. and Bae, K. H. : Cytotoxic triterpenoids from Alismatis Rhizoma. Arch. Pharm. Res. 24, 524 (2001)   DOI   ScienceOn
20 Maeda, H., Shin, Y. H., Akaike, T. and Yoshida, M. : Septic shock: prevention by NO-scavenger (PTIO) and by kinin inhibitor. Shock, Elsevier Science B.V. 43-52 (1996)
21 Wolfram, B. and Robert, H. : Natural proteinase inhibitors and their interaction with proteinase. Eur. J. Biochem. 204, 433 (1992)
22 Namba, T. : The encyclopedia of Wakan-Yaku with color picture Vol. 1. Osaka Japan, Hoikusha Co., Ltd., pp. 99-101 (1993)
23 Kinoshita, C., Shin, Y. H., Akaike, T. and Maeda, H. : Effect of succinylated gelatin conjugated soybean trypsin inhibitor (SBTI) against hypotension and septic shock. Drug Delivery System 12, 335 (1997)
24 Kim, S. D., Park, G. H., Joo, W. A., Paik, W. K., Cook, R. J. and Williams, K. R. : Identification of protein-arginine Nmethyltransferase as 10-formyl tetrahydrofolate dehydrogenase. J. Biol. Chem. 273, 27374 (1998)
25 Moon, S. E. and Shin, Y. H. : Characterization and pharmacological effect of mungbean trypsin inhibitor. Kor. J. Life Sci. 12, 528 (2002)